Daniel Catovsky

Q: What Schools Are Affiliated With Daniel Catovsky

Daniel Catovsky is affiliated with the following schools: Institute of Cancer Research, University of Oxford, Royal Postgraduate Medical School, University of Birmingham

Daniel Catovsky's AcademicInfluence.com Rankings

Daniel Catovsky

Philosophy

#2357

World Rank

#4056

Historical Rank

Logic

#541

World Rank

#985

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Daniel Catovsky Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Daniel Catovsky's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group (1976) (5498)
Proposals for the classification of the myelodysplastic syndromes (1982) (3839)
Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. (1985) (3172)
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. (2008) (3147)
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. (2018) (874)
The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. (1994) (816)
Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. (1985) (718)
Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. (1989) (689)
Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO) (1991) (669)
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial (2007) (592)
The human type‐C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T‐cell leukemia/lymphoma (1982) (546)
Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia. (1997) (536)
The Morphological Classification of Acute Lymphoblastic Leukaemia: Concordance among Observers and Clinical Correlations (1981) (502)
ADULT T-CELL LYMPHOMA-LEUKAEMIA IN BLACKS FROM THE WEST INDIES (1982) (487)
Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. (1991) (423)
The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: Proposals by the French ‐ American ‐ British Cooperative Leukaemia Group (1994) (420)
A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients (1997) (409)
A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia (2008) (380)
Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). (1997) (371)
Hairy cell leukemia: a clinical review based on 71 cases. (1978) (339)
Levels of expression of CD19 and CD20 in chronic B cell leukaemias. (1998) (321)
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. (2001) (302)
Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients (1996) (298)
Chemotherapeutic Options in Chronic Lymphocytic Leukemia: a Meta-analysis of the Randomized Trials (1999) (295)
Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. (1986) (293)
A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. (2003) (290)
1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. (1983) (286)
Clustering of missense mutations in the ataxia-telanglectasia gene in a sporadic T-cell leukaemia (1997) (281)
Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial. (2011) (271)
Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H. (1998) (268)
Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk (2010) (243)
Humanized CD52 monoclonal antibody campath‐1H as first‐line treatment in chronic lymphocytic leukaemia (1996) (241)
Classification of Acute Leukemia (1977) (238)
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. (2013) (235)
Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. (2002) (234)
Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival (1989) (232)
A VARIANT FORM OF HYPERGRANULAR PROMYELOCYTIC LEUKAEMIA (M3) (1980) (224)
Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis (2009) (213)
Definition of acute biphenotypic leukemia. (1997) (213)
Chronic Lymphocytic Leukaemia: Proposals for a Revised Prognostic Staging System (1981) (211)
Treatment of T-cell prolymphocytic leukemia with human CD52 antibody. (1997) (200)
The histopathology of splenic lymphoma with villous lymphocytes. (1994) (199)
Association of the human type C retrovirus with a subset of adult T-cell cancers. (1983) (197)
SCANNING ELECTRON MICROSCOPY AND THE NATURE OF THE HAIRY CELL (1975) (197)
The B‐Lymphocyte Nature of the Hairy Cell of Leukaemic Reticuloendotheliosis (1974) (197)
Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia (1987) (192)
Phenotypic heterogeneity and cellular origins of T cell malignancies. (1981) (188)
Chronic Myelomonocytic Leukaemia (1975) (187)
Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial. (2012) (184)
The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. (1994) (183)
Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. (1998) (183)
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia (2013) (183)
Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia. (2005) (183)
Splenic B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens. (1987) (180)
SEPTICAEMIA CAUSED BY VIRIDANS STREPTOCOCCI IN NEUTROPENIC PATIENTS WITH LEUKAEMIA (1983) (179)
The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. (1994) (175)
Prolymphocytic leukaemia of B and T cell type. (1973) (174)
Outcome of biphenotypic acute leukemia. (1999) (171)
Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases (1991) (170)
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia (1986) (169)
Hairy-cell leukaemia and prolymphocytic leukaemia. (1977) (168)
Leukaemic Reticuloendotheliosis (‘Hairy’ Cell Leukaemia): A Distinct Clinico‐Pathological Entity (1974) (167)
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. (2017) (167)
A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. (1985) (164)
Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology. (1993) (163)
Cytochemical profile of B and T leukaemic lymphocytes with special reference to acute lymphoblastic leukaemia (1974) (156)
‘Prolymphocytoid’ Transformation of Chronic Lymphocytic Leukaemia (1979) (154)
The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. (1994) (150)
Blast Crisis of Chronic Myeloid Leukaemia (CML): II. CELL SURFACE MARKER ANALYSIS OF ‘LYMPHOID’AND MYELOID CASES (1976) (146)
Subcutaneous CAMPATH‐1H in fludarabine‐resistant/relapsed chronic lymphocytic and B‐prolymphocytic leukaemia (1997) (145)
Chronic T cell lymphocytosis: a review of 21 cases (1984) (140)
The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. (2008) (139)
TERMINAL DEOXYNUCLEOTIDYL-TRANSFERASE LEVELS AND MEMBRANE PHENOTYPES IN DIAGNOSIS OF ACUTE LEUKÆMIA (1977) (138)
Cutaneous findings in chronic lymphocytic leukaemia (2004) (136)
Ph1‐POSITIVE ACUTE LEUKAEMIA AND CHRONIC GRANULOCYTIC LEUKAEMIA: ONE OR TWO DISEASES? (1979) (135)
Monoclonal integration of HTLV‐I proviral DNA in patients with strongyloidiasis (1987) (135)
Chronic lymphocytic leukaemia/small lymphocytic leukaemia. (2001) (133)
A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients. (1990) (132)
Cytogenetic findings in acute biphenotypic leukaemia. (1996) (132)
Cytogenetic studies in splenic lymphoma with villous lymphocytes (1993) (132)
MARROW TRANSPLANTATION FOR PATIENTS IN THE CHRONIC PHASE OF CHRONIC GRANULOCYTIC LEUKAEMIA (1982) (132)
Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Third International Workshop on Chromosomes in Leukemia. (1983) (130)
Familial chronic lymphocytic leukaemia: a survey and review of published studies (2000) (130)
Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation (2010) (130)
Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients (2003) (129)
The Association of Eosinophilia with Lymphoblastic Leukaemia or Lymphoma: a Study of Seven Patients (1980) (125)
Heterogeneity of B-cell leukemias demonstrated by the monoclonal antibody FMC7 (1981) (124)
Malignant Histiocytosis: A Clinico‐pathological Study of 12 Cases (1978) (122)
Mouse Red‐Cell Rosettes in B‐Lymphoproliferative Disorders (1976) (121)
Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin’s lymphomas. Functional studies in a cell line (Granta 519) (1997) (121)
The variant form of hairy-cell leukaemia. (2003) (120)
Clinical significance of T-cells in chronic lymphocytic leukaemia. (1974) (119)
Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone (2006) (119)
Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. (2006) (117)
Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. (1999) (117)
Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia. (1987) (116)
Prognostic significance of chromosome abnormalities in chronic lymphocytic leukaemia (1984) (116)
A variant form of hypergranular promyelocytic leukemia (M3) (1980) (115)
Evidence for human T cell lymphoma-leukemia virus infection of family members of human T cell lymphoma-leukemia virus positive T cell leukemia-lymphoma patients (1983) (115)
Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses. (2005) (113)
High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities (2003) (111)
Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia. (1991) (111)
p53 abnormalities in B-cell prolymphocytic leukemia. (1997) (110)
The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. (2004) (110)
Megakaryoblastic leukemia presenting as acute myelofibrosis -- a study of four cases with the platelet-peroxidase reaction (1981) (110)
The natural history and clinico-pathological features of the variant form of hairy cell leukemia (2001) (109)
p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis (1997) (108)
Long remissions in hairy cell leukemia with purine analogs (2005) (108)
The morphological spectrum of T‐prolymphocytic leukaemia (1986) (108)
Interferon is effective in hairy‐cell leukaemia (1985) (108)
Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia. (1996) (108)
Clinical-cytogenetic correlations in myelodysplasia (preleukemia). (1989) (108)
Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia (1997) (107)
Cytogenetic Findings and Survival in B-cell Chronic Lymphocytic Leukemia. Second IWCCLL Compilation of Data on 662 Patients. (1991) (107)
Lineage commitment in biphenotypic acute leukemia. (1993) (107)
Multiparameter studies in lymphoid leukemias. (1979) (105)
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia (1986) (102)
Molecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon. (1996) (101)
Fludarabine phosphate for the treatment of low grade lymphoid malignancy. (1991) (100)
p53 abnormalities in splenic lymphoma with villous lymphocytes. (2001) (99)
Chemotherapy and autografting for chronic granulocytic leukaemia in transformation: probable prolongation of survival for some patients (1984) (98)
Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12 (1997) (97)
A classification of acute leukaemia for the 1990s (1991) (96)
Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene. (1994) (96)
ATM is usually rearranged in T-cell prolymphocytic leukaemia (1998) (96)
Recommended methods for cytological procedures in haematology. International Committee for Standardization in Haematology (ICSH). (1985) (95)
Cryopreserved peripheral blood cells functioning as autografts in patients with chronic granulocytic leukaemia in transformation. (1979) (95)
In vivo‘Purging’ of residual disease in CLL with Campath‐1H (1997) (95)
Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis. (2005) (95)
Membrane marker and cell separation studies in Ph1-positive leukemia. (1978) (95)
Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization. (1998) (94)
HTLV-1 envelope sequences from Brazil, the Caribbean, and Romania: clustering of sequences according to geographic origin and variability in an antibody epitope. (1991) (94)
T-lymphoblastic Leukaemia: A Distinct Variant of Acute Leukaemia (1974) (94)
Clinical staging and immunological findings in chronic lymphocytic leukemia (1979) (93)
T‐cell large granular lymphocyte leukemia (2006) (93)
Hairy cell leukemia (HCL) variant: an intermediate disease between HCL and B prolymphocytic leukemia. (1984) (92)
Quantitative flow cytometry can distinguish between normal and leukaemic B‐cell precursors (1995) (89)
Increase in Ty Lymphocytes in B‐Cell Chronic Lymphocytic Leukaemia (1981) (89)
Prolymphocytic Leukaemia (1974) (89)
Differential expression of CD3 and CD7 in T‐cell malignancies: a quantitative study by flow cytometry (1996) (88)
Characterization of blast cells in chronic granulocytic leukaemia in transformation, acute myelofibrosis and undifferentiated leukaemia (1985) (88)
Airways obstruction associated with graft versus host disease after bone marrow transplantation. (1984) (88)
Long‐term follow‐up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine (1999) (88)
Interstitial insertion of retinoic acid receptor-alpha gene in acute promyelocytic leukemia with normal chromosomes 15 and 17. (1994) (87)
Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases. (1989) (87)
Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis (1989) (86)
Rapid Molecular Cloning of Rearrangements of the IGHJ Locus Using Long- Distance Inverse Polymerase Chain Reaction (1997) (86)
Blast Crisis of Chronic Myeloid Leukaemia (CML): I. PRESENTATION SIMULATING ACUTE LYMPHOID LEUKAEMIA (ALL) (1976) (86)
Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b). (1996) (86)
Polyclonal integration of HTLV‐I proviral DNA in lymphocytes from HTLV‐I seropositive individuals: an intermediate state between the healthy carrier state and smouldering ATL (1988) (85)
CO-TRIMOXAZOLE FOR PREVENTION OF INFECTION IN ACUTE LEUKÆMIA (1978) (84)
TCL1 is activated by chromosomal rearrangement or by hypomethylation (2001) (84)
ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial (2014) (84)
Myelomonocytic leukaemia supervening on chronic lymphocytic leukaemia. (1971) (84)
A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia. (2007) (83)
A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors. (1997) (83)
Chronic Granulocytic Leukaemia: Effect of Elective Splenectomy on the Course of Disease (1975) (81)
Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. (2002) (81)
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. (2012) (81)
Splenic B cell lymphoma with "villous" lymphocytes in the peripheral blood: a disorder distinct from hairy cell leukemia. (1987) (81)
A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci. (2005) (80)
The fine structure of normal lymphocyte subpopulations--a study with monoclonal antibodies and the immunogold technique. (1982) (80)
ACID-PHOSPHATASE REACTION IN ACUTE LYMPHOBLASTIC LEUKÆMIA (1978) (80)
Anticipation in familial chronic lymphocytic leukaemia (1998) (79)
Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant* (2012) (78)
Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia. (2001) (78)
Megakaryoblastic transformation of chronic granulocytic leukaemia. An electron microscopy and cytochemial study. (1977) (77)
Simultaneous or Spontaneous Occurrence of Lympho‐ and Myeloproliferative Disorders: a Report of Four Cases (1981) (77)
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia (1986) (77)
Unusual T‐Cell Phenotype in Advanced B‐Chronic Lymphocytic Leukaemia (1981) (77)
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia (2017) (77)
Delineation of the minimal region of loss at 13q14 in multiple myeloma (2003) (77)
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia (1987) (76)
HAIRY-CELL LEUKÆMIA WITH POLYARTHRITIS NODOSA (1979) (76)
Chromosome abnormalities at 11q13 in B cell tumours (1988) (75)
The role of ultrastructural cytochemistry and monoclonal antibodies in clarifying the nature of undifferentiated cells in acute leukaemia (1988) (75)
Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia. (1996) (75)
Reciprocal 8;14 translocation in EBV‐negative B‐cell acute lymphocytic leukemia with burkitt‐type cells (1979) (73)
5th International Workshop on Chronic Lymphocytic Leukemia. (1992) (73)
Heterogeneity of T‐cell beta‐chain gene rearrangements in human leukaemias and lymphomas. (1985) (73)
Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015) (72)
Translocation t(11; 14)(q 13;q32) in chronic lymphoid disorders (1992) (72)
Adult T-cell leukaemia/lymphoma in Brazil and its relation to HTLV-1 (1990) (72)
Myeloperoxidase-deficient neutrophils in acute myeloid leukaemia. (2009) (72)
Chronic T-cell leukemias. I. Morphology, cytochemistry and ultrastructure. (1980) (71)
Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route. (2011) (71)
Detection of minimal residual disease in B‐lineage acute lymphoblastic leukaemia by quantitative flow cytometry (1998) (71)
Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy? (2003) (70)
Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias (1997) (70)
Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia (2005) (70)
T‐cell malignancies in Brazil. Clinico‐pathological and molecular studies of HTLV‐I‐positive and ‐negative cases (1995) (69)
Membrane phenotyping: diagnosis, monitoring and classification of acute 'lymphoid' leukaemias. (1977) (69)
Disease Features in Acute Myeloid Leukemia with t(8;21)(q22;q22). Influence of Age, Secondary Karyotype Abnormalities, CD19 Status, and Extramedullar Leukemia on Survival (2000) (69)
Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma (2012) (68)
B‐prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia (2004) (68)
Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B (2003) (67)
The role of an anti‐myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry (1992) (67)
ζ‐Chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia (2005) (67)
The efficacy of alemtuzumab for refractory chronic lymphocytic leukemia in relation to cytogenetic abnormalities of p53. (2005) (66)
Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. (1997) (66)
Association between sarcoidosis and lymphoma revisited. (1996) (65)
Genetic susceptibility to chronic lymphocytic leukemia (2002) (65)
Mycosis fungoides and Sezary syndrome are not associated with HTLV‐I infection: an international study (1997) (64)
Deoxycoformycin in the treatment of mature T-cell leukaemias. (1991) (64)
T‐cell functional abnormality in B‐chronic lymphocytic leukaemia: evidence of a defect of the T‐helper subset (1983) (64)
Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) mice (1998) (64)
In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40. (1993) (63)
Disease burden of chronic lymphocytic leukaemia within the European Union (2008) (63)
High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy (2008) (63)
Sideroblastic Anaemia and its Association with Leukaemia and Myelomatosis: A Report of Five Cases (1971) (63)
Long-term results for pentostatin and cladribine treatment of hairy cell leukemia (2011) (62)
Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation. (2011) (62)
Increase of T lymphocytes in the spleen in Hodgkin's disease. (1974) (62)
Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry. (1996) (62)
Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM‐P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non‐Hodgkin's lymphoma (2003) (61)
Alemtuzumab in T-cell malignancies (2002) (61)
The t(14;19)(q32;q13)‐positive small B‐cell leukaemia: a clinicopathologic and cytogenetic study of seven cases (2007) (61)
Interphase cytogenetics in chronic lymphocytic leukemia. (1997) (61)
Stem cell transplantation after alemtuzumab in T‐cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study (2010) (60)
Anaemia in myelofibrosis: its value in prognosis (1983) (60)
Long term results with 2'deoxycoformycin in hairy cell leukemia. (1994) (60)
T-CELL ORIGIN OF ACID-PHOSPHATASE-POSITIVE LYMPHOBLASTS (1972) (60)
An oxaliplatin‐based chemotherapy in patients with relapsed or refractory intermediate and high‐grade non‐Hodgkin's lymphoma (2001) (60)
A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders (2003) (59)
The Leukemic Presentation of Mantle-cell Lymphoma: Disease Features and Prognostic Factors in 58 Patients (2004) (59)
The clinical significance of patients’ sex in chronic lymphocytic leukemia (2014) (59)
Causation of chronic lymphocytic leukemia--insights from familial disease. (2003) (58)
Diagnostic significance of CD20 and FMC7 expression in B-cell disorders. (2003) (57)
High‐grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis (2008) (57)
The Lymphoid Leukaemias (1990) (57)
Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia (1988) (56)
The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: a long‐term follow‐up study (1997) (56)
STRONGYLOIDES STERCORALIS AS CANDIDATE CO-FACTOR FOR HTLV-I-INDUCED LEUKAEMOGENESIS (1987) (56)
Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. (2004) (56)
Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia. (2004) (56)
The human T-cell lymphotropic viruses types I/II are not involved in T prolymphocytic leukemia and large granular lymphocytic leukemia (1997) (55)
Patients’ experience of chronic lymphocytic leukaemia: baseline health‐related quality of life results from the LRF CLL4 trial (2008) (55)
The value of scoring systems for the diagnosis of biphenotypic leukemia and mature B-cell disorders. (1994) (55)
T cell disorders in haematological diseases. (1982) (55)
CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3. (1991) (54)
The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma (2012) (54)
Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia. (2005) (54)
Prolymphocytic Leukaemia: an Ultrastructural Study of 22 Cases (1980) (53)
Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia. (2016) (53)
Megakaryoblastic leukemia presenting as acute myelofibrosis -- a study of four cases with the platelet-peroxidase reaction. (1981) (53)
Analysis of residual disease in chronic lymphocytic leukemia by flow cytometry (1997) (53)
Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia (1996) (52)
Splenic Lymphoma with Villous Lymphocytes (1992) (52)
Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL) (2000) (52)
Hairy cell leukemia: a five-year update on seventy-one patients. (1983) (51)
Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL (2008) (51)
Histopathology of the Spleen in T-Cell Large Granular Lymphocyte Leukemia and T-Cell Prolymphocytic Leukemia: A Comparative Review (2005) (51)
Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism (2016) (51)
Abnormalities of chromosome 7q and Tac expression in T cell leukemias. (1986) (51)
Candidate counterparts of Sézary cells and adult T-cell lymphoma-leukaemia cells in normal peripheral blood: an ultrastructural study with the immunogold method and monoclonal antibodies. (1983) (51)
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia (2007) (51)
Inherited genetic susceptibility to monoclonal B-cell lymphocytosis. (2010) (51)
Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity. (1992) (51)
Cutaneous infiltration in T‐cell prolymphocytic leukaemia (1995) (50)
Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma (2005) (50)
Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations. (2003) (50)
Correlation between chromosomal abnormalities and blast phenotype in the blast crisis of Ph-positive CGL. (1986) (50)
High dose methyl prednisolone in refractory chronic lymphocytic leukaemia. (1999) (50)
Trisomy 12 in B‐cell chronic lymphocytic leukaemia: assessment of lineage restriction by simultaneous analysis of immunophenotype and genotype in interphase cells by fluorescence in situ hybridization (1994) (49)
Blast crisis of chronic granulocytic leukemia with mast cell and basophilic precursors. (1985) (49)
Bone marrow transplantation for primary refractory acute leukaemia. (1994) (49)
Chromosome abnormalities in B-cell prolymphocytic leukemia: a study of nine cases. (1983) (49)
Long-term follow-up after purine analogue therapy in hairy cell leukaemia (2015) (49)
Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH (2007) (49)
The Significance of Lysozyme Estimations in Acute Myeloid and Chronic Monocytic Leukaemia (1971) (48)
Terminal deoxynucleotidyl-transferase levels and membrane phenotypes in diagnosis of acute leukaemia. (1977) (48)
Familial Acute Myeloid Leukaemia with Acquired Pelger-Huët Anomaly and Aneuploidy of C Group (1972) (48)
Thromboembolic Complications in Myelomatosis (1970) (48)
DNA rearrangements of immunoglobulin genes correlate with phenotypic markers in B-cell malignancies. (1984) (48)
Cytogenetic studies on prolymphocytic leukemia. II. T cell prolymphocytic leukemia. (1987) (48)
Myelodysplastic relapse of de novo acute myeloid leukaemia with trilineage myelodysplasia: a previously unrecognized correlation (1988) (48)
Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin's lymphoma with leukemia. (2002) (48)
Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL. (1998) (47)
Splenic Red Cell Pooling in Hairy Cell Leukaemia (1977) (47)
CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia. (2004) (47)
Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity. (1995) (47)
Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia (1986) (46)
Histological Study of Bone Marrow Regeneration following Chemotherapy for Acute Myeloid Leukaemia and Chronic Granulocytic Leukaemia in Blast Transformation (1980) (46)
Transformation of T‐cell large granular lymphocyte leukaemia into a high‐grade large T‐cell lymphoma (2001) (46)
Characteristic appearances of the bone marrow in T‐cell large granular lymphocyte leukaemia (2007) (46)
Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donors. (1990) (46)
Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial (2015) (46)
Histiocytic medullary reticulosis complicating chronic lymphocytic leukaemia: malignant or reactive? (2009) (46)
Pharmacokinetics and metabolism of chlorambucil in patients with malignant disease. (1979) (46)
Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence (2011) (46)
Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus. (1996) (45)
Cytochemical markers of differentiation in acute leukemia. (1981) (45)
Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes (2003) (45)
Adult acute lymphoblastic leukaemia: a study of prognostic features and response to treatment over a ten year period. (1986) (45)
Multiple‐drug chemotherapy for acute leukemia. The TRAMPCOL regimen: Results in 86 patients (1977) (45)
Spontaneous clinical regression in chronic lymphocytic leukaemia (2002) (45)
Diagnostic issues in chronic lymphocytic leukaemia (CLL). (2010) (45)
POLYARTERITIS NODOSA AND HAIRY-CELL LEUKÆMIA (1979) (44)
FISH analysis for BCL-1 rearrangements and trisomy 12 helps the diagnosis of atypical B cell leukaemias (1999) (44)
Activation and immortalization of leukaemic B cells by epstein‐barr virus (1989) (44)
Mature T-Cell Leukemias and Leukemia/Lymphoma Syndromes: Review of Our Experience in 175 Cases. (1991) (43)
Rearrangement of the T-cell receptor delta genes in human T-cell leukemias. (1989) (43)
Massive abdominal lymphadenopathy in hairy cell leukaemia: a report of 12 cases (1992) (43)
Acquired angioedema as the presenting feature of lymphoproliferative disorders of mature B‐lymphocytes (1993) (43)
IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL) (2006) (43)
Reversal of marrow fibrosis in acute megakaryoblastic leukaemia after remission‐induction and consolidation chemotherapy followed by bone marrow transplantation (1983) (43)
The membrane phenotype of T-prolymphocytic leukaemia. (2009) (43)
The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH (1999) (43)
Adult T‐Cell leukemia/lymphoma: A working point‐score classification for epidemiological studies (1994) (42)
Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk (2010) (42)
The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement. (1988) (42)
The membrane phenotype of hairy cell leukemia: a study with monoclonal antibodies. (1984) (42)
The 14q+ marker in hairy cell leukaemia. A cytogenetic study of 15 cases. (1986) (42)
Clinical spectrum of lymphoproliferative diseases (1978) (42)
Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A. (2003) (41)
Chlorambucil--still not bad: a reappraisal. (2011) (41)
Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults (2006) (41)
mb-1: A New Marker for B-Lineage Lymphoblastic Leukemia (1993) (41)
Alpha, beta and gamma T-cell receptor genes: rearrangements correlate with haematological phenotype in T cell leukaemias. (1987) (41)
Guidelines for the treatment of hairy cell leukemia. (1987) (41)
p53 gene deletion and trisomy 12 in hairy cell leukemia and its variant. (1999) (41)
α, β and γ T‐cell receptor genes: rearrangements correlate with haematological phenotype in T cell leukaemias (1987) (41)
HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic response. (1988) (41)
Translocations t(14;18) and t(8;14) with rearranged bcl-2 and c-myc in a case presenting as B-ALL (L3). (1991) (40)
Functional properties of neoplastic T cells in adult T cell lymphoma/leukemia patients from the Caribbean. (1984) (40)
Heterogeneity of B-cell leukemias demonstrated by the monoclonal antibody FMC7. (1981) (40)
Adenosine deaminase concentrations in leukaemia and lymphoma: relation to cell phenotypes. (1981) (40)
CO-TRIMOXAZOLE ALONE FOR PREVENTION OF BACTERIAL INFECTION IN PATIENTS WITH ACUTE LEUKAEMIA (1982) (40)
Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay. (1995) (40)
Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia. (2016) (40)
Eovist Injection and Resovist Injection: two new liver-specific contrast agents for MRI. (2000) (40)
High-resolution genomic profiling in hairy cell leukemia-variant compared with typical hairy cell leukemia (2011) (39)
Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia. (1984) (39)
Transport of Methotrexate into Normal Haemopoietic Cells and into Leukaemic Cells and its Effects on DNA Synthesis (1973) (39)
Fatal cardiac arrest during continuous ambulatory monitoring. (1981) (39)
Serum C-reactive protein levels in the management of infection in acute leukaemia. (1984) (39)
Analysis of clonal rearrangements of the Ig heavy chain locus in acute leukemia. (1996) (39)
Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia (1999) (39)
Production of colony-stimulating factor by leukemic leukocytes. (1976) (38)
Morphology and immunology of circulating cells in leukaemic phase of follicular lymphoma. (1988) (38)
Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis. (2008) (38)
Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia. (2000) (38)
COMPLETE REMISSION IN PROLYMPHOCYTIC LEUKAEMIA WITH THE COMBINATION CHEMOTHERAPY—CHOP (1979) (38)
Splenic angiosarcoma following chemotherapy for follicular lymphoma. (1986) (38)
Studies in healthy human T‐cell‐leukemia lymphoma virus (HTLV‐I) carriers from the Caribbean (1986) (38)
Deoxycoformycin in the treatment of mature B-cell malignancies. (1990) (37)
Splenectomy in lymphoproliferative disorders: a report on 70 cases and review of the literature. (1993) (37)
HTLV-I and HTLV-II infections in hematologic disorder patients, cancer patients, and healthy individuals from Rio de Janeiro, Brazil. (1997) (37)
The histopathology of prolymphocytic leukaemia with particular reference to the spleen: a comparison with chronic lymphocytic leukaemia (1980) (37)
T-cell leukemias with rearrangement of the gamma but not beta T-cell receptor genes. (1988) (37)
Isolated Bone Marrow Involvement in Diffuse Large B Cell Lymphoma: A Report of Three Cases with Review of Morphological, Immunophenotypic and Cytogenetic Findings (2004) (36)
Incidence and significance of abdominal lymphadenopathy in hairy cell leukaemia. (1994) (36)
B-cell prolymphocytic leukemia and chronic lymphocytic leukemia have distinctive gene expression signatures (2009) (36)
Assessment of fl udarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial (2007) (36)
Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies. (2001) (36)
Response to phytohaemagglutinin and pokeweed mitogen in chronic lymphocytic leukaemia. (1972) (36)
The UK Medical Research Council CLL trials 1 and 2. (1988) (36)
Complete recovery of histiocytic medullary reticulosis‐like syndrome in a child with acute lymphoblastic leukemia (1983) (36)
ATM mutations are rare in familial chronic lymphocytic leukemia. (2002) (36)
Leukemic Cell (1981) (36)
The classification of acute leukaemia. (1992) (36)
Differential diagnosis in chronic lymphocytic leukaemia. (2007) (35)
2‐Chlorodeoxyadenosine in the treatment of hairy cell leukaemia: differences in response in patients with and without abdominal lymphadenopathy (1996) (35)
Demonstration of cytoplasmic and nuclear antigens in acute leukaemia using flow cytometry. (1994) (35)
The importance of CD34+/CD33− cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue (1998) (35)
Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial (2016) (35)
Leukaemia as a manifestation of large cell lymphoma (1991) (34)
Correlation of trisomy 12 with proliferating cells by combined immunocytochemistry and fluorescence in situ hybridization in chronic lymphocytic leukemia. (1996) (34)
The leukaemic phase of non-Hodgkin's lymphoma. (1995) (34)
Phase I/II evaluation of Pentostatin (2′-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemia (2004) (34)
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci (2017) (34)
Familial chronic lymphocytic leukemia. (2006) (34)
Cytochemistry of acid hydrolases in chronic B- and T-cell leukemias. (1982) (34)
Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia. (1988) (34)
B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells. (1990) (34)
REVERSAL OF BLAST-CELL CRISIS IN C.G.L. BY TRANSFUSION OF STORED AUTOLOGOUS BUFFY-COAT CELLS (1978) (34)
Hairy cell leukaemia. (2001) (33)
Early Results from LRF CLL4: A UK Multicenter Randomized Trial. (2005) (33)
Myeloid‐ and lymphoid‐specific breakpoint cluster regions in chromosome band 13q14 in acute leukemia (1999) (33)
Prolymphocytic Leukemia of B- and T-Cell Types (1984) (33)
Growth of human T-cell lineage acute leukemia in severe combined immunodeficiency (SCID) mice and non-obese diabetic SCID mice. (1997) (33)
Phagocytic potential of leukaemic B-lymphocytes. (2009) (33)
The effect of vitamin D3 metabolites on normal and leukemic bone marrow cells in vitro. (1984) (33)
Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial (2012) (33)
The translocation t(8;16)(p11;p13) defines an AML subtype with distinct cytology and clinical features (1992) (33)
Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia? (1997) (33)
Characterization of myeloid leukemias with monoclonal antibodies 3C5 and MY9 (1985) (33)
Establishment and characterization of three new malignant lymphoid cell lines (1987) (32)
Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL. (2008) (32)
Bone marrow fibre content in acute myeloid leukaemia before and after treatment. (1984) (32)
Ceftazidime as first-line therapy for fever in acute leukaemia. (1985) (32)
The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial (2016) (32)
Priapism complicating chronic granulocytic leukemia (1980) (32)
Haematological reconstitution and severity of graft‐versus‐host disease after bone marrow transplantation for chronic granulocytic leukaemia: the influence of previous splenectomy (1984) (32)
CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia. (2013) (32)
T-lymphocyte colonies in normal blood, bone marrow and lymphoproliferative disorders. (1979) (31)
Prognostic Factors in the UK LRF CLL4 Trial. (2005) (31)
Current concerns in haematology. 2: Classification of acute leukaemia. (1990) (31)
Hypokalaemia and raised lysozyme levels in acute myeloid leukaemia. (1973) (31)
The P2X7 receptor gene A1513C polymorphism does not contribute to risk of familial or sporadic chronic lymphocytic leukemia. (2004) (31)
Adult T-cell leukaemia/lymphoma in Brazil and its relation to HTLV-I. (1990) (31)
Expression of signal-transducing zeta chain in peripheral blood T cells and natural killer cells in patients with Hodgkin's disease in different phases of the disease. (1999) (31)
CLL family ‘Pedigree 14’ revisited: 1947–2004 (2005) (30)
Genetic variation in CXCR4 and risk of chronic lymphocytic leukemia. (2009) (30)
Similarities between T-cell chronic lymphocytic leukemia and the small-cell variant of T-prolymphocytic leukemia. (1996) (30)
Functional Analysis of the ATM-p53-p21 Pathway in the LRF CLL4 Trial: Blockade at the Level of p21 Is Associated with Short Response Duration (2012) (30)
Linkage analysis for major histocompatibility complex-related genetic susceptibility in familial chronic lymphocytic leukemia. (2000) (30)
Fine-scale mapping of the 6p25.3 chronic lymphocytic leukaemia susceptibility locus. (2010) (30)
Second malignancy in hairy cell leukaemia: no evidence of increased incidence after treatment with interferon alpha. (1996) (30)
Simultaneous demonstration of membrane antigens and cytochemistry at ultrastructural level: a study with the immunogold method, acid phosphatase and myeloperoxidase (1984) (30)
Fludarabine, Cyclophosphamide and Mitoxantrone in Relapsed or Refractory Chronic Lymphocytic Leukemia and Low Grade Non-Hodgkin's Lymphoma (2004) (30)
p53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T‐prolymphocytic leukaemia and Sezary syndrome (2000) (30)
Relationship of T leukaemias with cerebriform nuclei to T‐prolymphocytic leukaemia: a cytogenetic analysis with in situ hybridization (1997) (30)
Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion gene (2002) (30)
CD34 and CD117 are overexpressed in AML and may be valuable to detect minimal residual disease. (2002) (30)
Prolonged remission maintenance in acute myeloid leukaemia. (1977) (29)
Response to Therapy and Survival in CLL Is Influenced by Genetic Markers. Preliminary Analysis from the LRF CLL4 Trial. (2004) (29)
Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17) (2000) (29)
MARKER CHROMOSOME 14q+ IN FOLLICULAR LYMPHOMA IN TRANSFORMATION (1977) (29)
C-kit receptor (CD117) expression in acute leukemia. (1996) (29)
Lymphoma-like presentation of acute monocytic leukaemia. (1983) (29)
Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia (2006) (29)
Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial (2020) (29)
Lysozyme activity and nitroblue-tetrazolium reduction in leukaemic cells (1973) (29)
Paecilomyces varioti pneumonia complicating hairy cell leukaemia. (1985) (29)
B, T and “null” Cell Leukaemias (1975) (28)
B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene (1999) (28)
Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization. (2005) (28)
Formation of mouse red cell rosettes by "hairy" cells. (1975) (28)
Chronic T-cell leukemias. II. Cytogenetic studies. (1982) (28)
Prolymphocytic leukaemia: cell studies and treatment by leucapheresis. (1976) (28)
Immunological reconstitution after bone marrow transplant with Campath-1 treated bone marrow. (1987) (27)
REDUCED T‐COLONY FORMING CAPACITY BY T‐LYMPHOCYTES FROM B‐CHRONIC LYMPHOCYTIC LEUKAEMIA (1980) (27)
The search for genetic clues in chronic lymphocytic leukemia. (1997) (27)
Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer. (2016) (27)
Chronic Granulocytic Leukaemia: Multiple-drug Chemotherapy for Acute Transformation (1974) (27)
T-chronic lymphocytic leukaemia presenting as primary hypogammaglobulinaemia--evidence of a proliferation of T-suppressor cells. (1982) (27)
Chromosome and cell culture studies in eosinophilic leukaemia (1986) (26)
Serum Lysozyme and Vitamin B12 Binding Capacity in Myeloproliferative Disorders (1971) (26)
Infection of leukaemic B lymphocytes by Epstein Barr virus. (1993) (26)
Increase of T lymphocytes in the spleen in chronic granulocytic leukaemia. (1974) (26)
Splenic Irradiation in B‐Prolymphocytic Leukaemia (1981) (26)
5' nucleotidase activity in leukaemic lymphocytes. (1976) (26)
Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk (2011) (26)
Surface structure of normal and leukaemic lymphocytes. I. Effect of mitogens. (1972) (26)
p53 and mdm2 in mantle cell lymphoma in leukemic phase. (2002) (26)
Key issues in the treatment of chronic lymphocytic leukaemia (CLL) (1995) (26)
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk (2014) (25)
MTHFR polymorphisms and risk of chronic lymphocytic leukemia. (2004) (25)
Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics (2019) (25)
Chromosomal imbalances in familial chronic lymphocytic leukaemia: a comparative genomic hybridisation analysis (2002) (25)
Trisomy 14 in atypical chronic myeloid leukemia. (1990) (25)
MYELODYSPLASTIC SYNDROMES: IS ANOTHER CLASSIFICATION NECESSARY? (1984) (25)
Ultrastructural Cytochemistry of Leukaemic Cells: Characterization of the Early Small Granules of Monoblasts (1980) (25)
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology (2018) (25)
Drug cross‐resistance and therapy‐induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing (2009) (24)
Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia. (1981) (24)
Differential TdT expression in acute leukemia by flow cytometry: a quantitative study. (1995) (24)
Chromosome abnormalities in hairy cell leukaemia variant (1994) (24)
Lack of evidence of HHV-8 in mature T-cell lymphoproliferative disorders (1996) (24)
5′nucleotidase in cord blood lymphocytes (1977) (24)
Chronic lymphoproliferative disorders. (1995) (23)
Persistent polyclonal B-cell lymphocytosis. (1994) (23)
Cytochemical profile of megakaryoblastic leukaemia: a study with cytochemical methods, monoclonal antibodies, and ultrastructural cytochemistry. (1987) (23)
Phase II study of mitoxantrone and cytarabine in acute myeloid leukemia. (1987) (23)
Haematological Reconstitution after Autografting for Chronic Granulocytic Leukaemia in Transformation: the Influence of Previous Splenectomy (1980) (23)
Relationship between ARLTS1 polymorphisms and risk of chronic lymphocytic leukemia. (2006) (23)
High incidence of myelodysplasia and secondary leukaemia in the UK Medical Research Council Pilot of autografting in chronic lymphocytic leukaemia (2006) (23)
The U.K. experience with human lymphoblastoid interferon in HCL: a report of the first 50 cases. (1987) (23)
Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation. (1995) (23)
Histiocytic medullary reticulosis re-visited. (1981) (23)
Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy. (1995) (23)
Unusual deletions within the immunoglobulin heavy-chain locus in acute leukemias. (1993) (22)
Mouse RBC rosettes in chronic lymphocytic leukaemia: different expression in blood and tissues. (1980) (22)
Reduction in the stearic to oleic acid ratio in leukaemic cells — A possible chemical marker of malignancy (1985) (22)
Prolymphocytic leukaemia. (1974) (22)
Identical twin marrow transplantation for patients with leukemia and lymphoma. (1981) (22)
Characterization of B-cell leukemias: a tentative immunomorphological scheme. (1981) (22)
Molecular cytogenetic analysis in splenic lymphoma with villous lymphocytes: frequent allelic imbalance of the RB1 gene but not the D13S25 locus on chromosome 13q14. (1998) (22)
Pentostatin treatment of cutaneous T-cell lymphoma. (2000) (22)
Pentostatin and Cladribine in Hairy Cell Leukemia- a Retrospective Comparison of a Large Series with Long Follow up. (2004) (21)
Cytochemistry of normal lymphocyte subsets defined by monoclonal antibodies and immunocolloidal gold. (2009) (21)
Immunoglobulin gene rearrangements in hairy cell leukemia and other chronic B cell lymphoproliferative disorders. (1987) (21)
Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry (2002) (21)
Morphological and cytochemical identification of lymphoid cells. (1977) (21)
Immunophenotype Changes and Loss of CD52 Expression in Two Patients with Relapsed T-cell Prolymphocytic Leukaemia (2001) (21)
Very Low Seroprevalence of HTLV‐I/II in Cuba: Antibodies in Blood Donors and in Hematological and Nonhematological Patients (1991) (21)
EPIC: an effective low toxicity regimen for relapsing lymphoma. (1993) (21)
Measurement of serum C reactive protein concentration after bone marrow transplantation for leukaemia. (1984) (21)
Erythrocyte Sensitivity to In‐Vitro Lysis in Leukaemia (1971) (21)
Expression of TIA-1 and TIA-2 in T cell malignancies and T cell lymphocytosis. (1996) (21)
Splenectomy in mantle cell lymphoma with leukaemia: a comparison with chronic lymphocytic leukaemia (2002) (21)
Treatment of acute myeloid leukemia with intermediate-dose cytosine arabinoside and mitoxantrone. (1987) (21)
Treatment of Hairy Cell Leukaemia with 2'-Deoxycoformycin. (1990) (20)
Hypereosinophilic syndrome preceding T cell lymphoblastic lymphoma. (1985) (20)
Risk of developing chronic lymphocytic leukemia is influenced by HLA-A class I variation (2012) (20)
Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or marrow transplantation. (1997) (20)
VALUE OF LONG-CORE BIOPSY IN DETECTION OF DISCRETE BONE-MARROW LESIONS (1979) (20)
Immunoreactive calcitonin in leukaemia. (1979) (20)
Postgraduate Haematology: Hoffbrand/Postgraduate Haematology (2010) (20)
Fractionation of whole body irradiation before bone marrow transplantation for patients with leukaemia. (1983) (20)
T lymphoblastic transformation of refractory anaemia with excess of blasts. (1985) (20)
Expression of c-myc oncoprotein in chronic T cell leukemias. (1995) (20)
Chromosomes in leukemia (1977) (20)
Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas. (2005) (19)
The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity (2016) (19)
Incidence of MLL Rearrangement in Acute Myeloid Leukemia, and a CALM - AF10 Fusion in M4 Type Acute Myeloblastic Leukemia (2002) (19)
The impact of molecular cytogenetics on chronic lymphoid leukaemia. (1997) (19)
The histopathology of adult T‐cell lymphoma/leukaemia in blacks from the Caribbean (1983) (19)
Familial cancer associated with a polymorphism in ARLTS1. (2006) (19)
LYMPHOBLASTIC LEUKAEMIA IN SIAMESE TWINS: EVIDENCE FOR IDENTITY (1986) (18)
T‐cell prolymphocytic leukaemia: antigen receptor gene rearrangement and a novel mode of MTCP1 B1 activation (2000) (18)
Cytochemistry of normal and leukaemic lymphocytes: a review. (1979) (18)
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials. (2019) (18)
Appendix II: World Health Organization Classification of Tumours of the Haematopoietic and Lymphoid Tissues (2010) (18)
Definition and diagnosis of sporadic and familial chronic lymphocytic leukemia. (2004) (18)
Oestrogen receptor (ER) analysis in B-cell chronic lymphocytic leukemia: correlation of biochemical and immunocytochemical methods. (1990) (18)
Cytogenetic abnormalities in the leukemic phase of non-Hodgkin lymphoma. (1995) (18)
Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia. (1994) (18)
Biological Markers in Lymphoproliferative Disorders (1985) (17)
Dipeptidylaminopeptidase IV activity in normal and leukemic T-cell subpopulations. (1984) (17)
HTLV-I-POSITIVE T-CELL LYMPHOMA/LEUKAEMIA IN AN AFRICAN RESIDENT IN UK (1984) (17)
Spontaneous remission following bone marrow necrosis in chronic lymphocytic leukaemia. (1981) (17)
PLATINUM AGENTS AND SECONDARY MYELOID LEUKAEMIA: TWO CASES TREATED ONLY WITH PLATINUM‐BASED DRUGS (1996) (17)
Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukaemia. (1996) (17)
Fludarabine in lymphoproliferative disorders: the Royal Marsden Hospital experience. (1994) (17)
Association and clonal distribution of trisomy 12 and 13q14 deletions in chronic lymphocytic leukaemia (1998) (17)
Clinical experience with 2'-deoxycoformycin. (1996) (17)
The distribution of CD45R, CD29 and CD45RO (UCHL1) antigens in mature CD4 positive T‐cell leukaemias (1990) (17)
Sezary cell-like leukemia: a distinct type of mature T cell malignancy. (1990) (17)
T‐cell prolymphocytic leukaemia (2021) (16)
Bone marrow histological patterns in B-cell and T-cell prolymphocytic leukemia. (1989) (16)
Hairy-cell leukaemia with polyarteritis nodosa. (1979) (16)
Normal counterparts of hairy cells and B-prolymphocytes in the peripheral blood. An ultrastructural study with monoclonal antibodies and the immunogold method. (1985) (16)
Acute erythroid leukemia (M6): outcome of bone marrow transplantation. (1999) (16)
Lessons from a case of T-cell large granular lymphocytic leukaemia suggesting that immunomodulatory therapy is more effective than intensive treatment. (2005) (16)
A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial (2011) (16)
Correlation Between Morphology and Karotype (1984) (16)
Membrane phenotype and response to deoxycoformycin in mature T cell malignancies. (1987) (16)
Cutaneous presentation of chronic lymphatic leukaemia and response to ultraviolet B phototherapy (2001) (16)
Immunological studies in a case of T-cell leukaemia (1974) (15)
Granulomatous slack skin disease – disease features and response to pentostatin (2003) (15)
The Function of the Phagocytic Leucocytes in Leukaemia (1972) (15)
Chronic lymphocytic leukemia and prolymphocytic leukemia: a clinicopathological reappraisal. (1987) (15)
Cell markers and the classification of acute leukaemia. (1977) (15)
CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes (2013) (15)
Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia. (1996) (15)
Prolymphocytic leukemia of B cell type: rearranged immunoglobulin (Ig) genes with defective Ig production. (1985) (15)
Autografting for chronic granulocytic leukemia. (1981) (15)
Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial (2011) (15)
Liposomal vincristine for the treatment of human acute lymphoblastic leukaemia in severe combined immunodeficient (SCID) mice. (1998) (15)
Aberrant rearrangements within the immunoglobulin heavy chain locus in hairy cell leukemia. (1994) (14)
Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia. (2005) (14)
Unusual breakpoint distribution of 8p abnormalities in T-prolymphocytic leukemia: a study with YACS mapping to 8p11-p12. (2000) (14)
T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure. (1996) (14)
Analysis of helper activity on pokeweed mitogen- and interleukin 2-driven immunoglobulin synthesis by neoplastic T4+ cells. (1985) (14)
Bone marrow biopsy changes in acute myeloid leukaemia I: observations before chemotherapy (1985) (14)
Primary splenic hairy cell leukaemia: A case report and review of the literature (1987) (14)
Phenotypic conversion of TdT+ adult AML to CALLA+ ALL. (2009) (14)
Birth order pattern in the inheritance of chronic lymphocytic leukaemia and related lymphoproliferative disease (2007) (14)
CLL should be used only for the disease with B-cell phenotype. (1993) (14)
MITOZANTRONE AND HIGH-DOSE CYTARABINE IN ADULT ACUTE MYELOID LEUKAEMIA (1985) (14)
The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation. (1995) (14)
mb-1: a new marker for B-lineage lymphoblastic leukemia. (1993) (14)
Adult T-cell lymphoma/leukemia in a Caribbean patient: cytogenetic, immunologic, and ultrastructural findings. (1984) (14)
Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukaemia. (1993) (14)
Characterising the TP53-deleted subgroup of chronic lymphocytic leukemia: an analysis of additional cytogenetic abnormalities detected by interphase fluorescence in situ hybridisation and array-based comparative genomic hybridisation (2008) (13)
Similarities in mitochondrial ultrastructure of leukemic cells and ethidium-bromide-treated normal cells. (1982) (13)
Splenectomy for hairy cell leukaemia. (1981) (13)
Response to doxorubicin in hairy cell leukaemia. (2009) (13)
Variants in the ATM-BRCA 2-CHEK 2 axis predispose to chronic lymphocytic leukemia (2006) (13)
Biphenotypic leukaemia: a case of mixed T lymphoblastic and myeloblastic leukaemia. (1985) (13)
Characterisation of normal peripheral blood cells in cycle identified by monoclonal antibody Ki-67. (1992) (13)
CLINICAL MEASUREMENT OF SERUM C‐REACTIVE PROTEIN IN THE MONITORING AND DIFFERENTIAL DIAGNOSIS OF INFLAMMATORY DISEASES AND TISSUE NECROSIS AND IN THE RECOGNITION AND MANAGEMENT OF INTERCURRENT INFECTION (1982) (13)
MAINTENANCE AND CONSOLIDATION THERAPY IN AML (1984) (13)
Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985. (1987) (13)
Ultrastructural characteristics and lysozyme content in hypergranular and variant type of acute promyelocytic leukaemia (1998) (13)
Identical twin marrow transplantation for 5 patients with chronic myeloid leukaemia: Role of DNA finger‐printing to confirm monozygosity in 3 cases (1987) (13)
Acute myelomonocytic leukemia with t(10;11)(p13;q23): Heterogeneity of breakpoints at 11q23 and association with recombinase activation (1994) (13)
Neonatal mixed lineage acute leukaemia. (1994) (13)
Common genetic variation contributes significantly to the risk of developing chronic lymphocytic leukemia (2013) (13)
Cell Membrane Enzymes: L‐γ‐Glutamyl Transpeptidase, Leucine Aminopeptidase, Maltase and Trehalase in Normal and Leukaemic Lymphocytes (1978) (13)
Chronic Lymphocytic Leukaemia and other B‐Cell Disorders (2007) (13)
T OR B LYMPHOCYTES IN CHRONIC LYMPHOCYTIC LEUKÆMIA (1971) (13)
Institute-Working Group (NCI-WG) 1996 guidelines Lymphocytic Leukemia (IWCLL) updating the National Cancer leukemia: a report from the International Workshop on Chronic Guidelines for the diagnosis and treatment of chronic lymphocytic (2008) (12)
Markers of differentiated B cell leukaemia: CD22 antibodies and FMC7 react with different molecules. (1987) (12)
[Retroviruses and leukemia]. (1984) (12)
Clinical overview of pentostatin (Nipent) use in lymphoid malignancies. (2000) (12)
Myeloperoxidase cytochemistry using 2, 7-fluorenediamine. (1978) (12)
Cell Volume Studies in B‐Cell Leukaemia (1980) (12)
Immunological, ultrastructural and molecular features of unclassifiable acute leukaemia. (1993) (12)
Reduced T-colony forming capacity in B-chronic lymphocytic leukaemia.--II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia. (1982) (12)
Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case. (1992) (12)
T-cell chronic lymphocytic leukaemia: the spectrum of mature T-cell disorders. (1988) (12)
Incidence of Hemolytic Anemia after Chemotherapy in the CLL4 Trial. A Possible Protective Role for Fludarabine Plus Cyclophosphamide. (2004) (12)
Splenectomy in advanced chronic lymphocytic leukaemia. (1987) (12)
Different expression of CD3 and CD22 in leukemic cells according to whether tested in suspension or fixed on slides. (1988) (11)
HTLV-I positive adult T-cell leukaemia/lymphoma (ATLL) in Chile. (1994) (11)
Morphometric analysis of chronic B-cell leukemias--an aid to the classification of lymphoid cell types. (1989) (11)
Significance of Phi bodies in acute leukaemia. (1981) (11)
Quantification of P-glycoprotein in chronic lymphocytic leukemia by flow cytometry. (1997) (11)
The Classification of Lymphoid Leukaemias. (1991) (11)
Evidence that T colony formation is a property of T mu (helper) lymphocytes. (1980) (11)
Different reactivity of monoclonal antibodies against common acute lymphoblastic leukaemia antigen (CD10). (1987) (11)
Cell Membrane Enzymes II. (1978) (11)
Comparison of immunoperoxidase staining with indirect immunofluorescence, ELISA, and Western blotting assays for detecting anti-HTLV-I antibodies in systemic lupus erythematosus. (1988) (11)
The long‐term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 years (2015) (11)
Monoclonal antibody OKT17 recognizes most cases of T‐cell malignancy (1985) (10)
Role of CD34+ cells in engraftment after high-dose melphalan in multiple myeloma patients given peripheral blood stem cell rescue. (1996) (10)
Germline mutations in RAD51, RAD51AP1, RAD51B, RAD51C,RAD51D, RAD52 and RAD54L do not contribute to familial chronic lymphocytic leukemia (2008) (10)
Biochemical mechanisms of deoxycoformycin toxicity in chronic leukemias. (1987) (10)
A t(8;14)(q24;q32) in a T-lymphoma/leukemia of CD8+ large granular lymphocytes. (1987) (10)
Classification of mature T-cell leukemias. (2004) (10)
Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) region. (2004) (10)
Histological study of the bone marrow in chronic granulocytic leukaemia in blast transformation. II. Bone marrow fibre content before and after autografting (1981) (10)
Cytochemistry: an aid to the diagnosis and classification of the acute leukemias. (1978) (10)
Cell Surface and Enzyme Markers of Cord Blood Lymphocytes (1980) (10)
NEW COMBINATION CHEMOTHERAPY FOR RELAPSED ACUTE MYELOID LEUKAEMIA (1984) (10)
Increased sex concordance of sibling pairs with chronic lymphocytic leukemia (2004) (10)
Instability of CAG-trinucleotide Repeats in Chronic Lymphocytic Leukemia (2002) (10)
Stimulation of chronic lymphatic leukaemia cells by pokeweed mitogen after treatment with neuraminidase-galactose oxidase. (1981) (10)
Reactivity of the monoclonal antibody RFB1 in chronic B-cell leukaemias. (2009) (10)
Morphological heterogeneity of Leu7, Leu11 and OKM1 positive lymphocyte subsets: an ultrastructural study with the immunogold method. (1987) (10)
Characterization by ultrastructural cytochemistry of normal and leukemic myeloid cells reacting with monoclonal antibodies. (1984) (10)
Paroxysmal nocturnal haemoglobinuria-like red cell abnormality in patient with lymphoproliferative disease. (1972) (10)
Heterogeneity of breakpoints at the transcriptional co-activator gene, BOB-1, in lymphoproliferative disease. (1996) (10)
C-kit receptor (CD0117) expression in acute leukemia (2004) (9)
Immunological and ultrastructural studies in acute biphenotypic leukaemia. (1993) (9)
Pregnancy improves neutropenia in T‐cell large granular lymphocyte leukaemia (2005) (9)
Common variation at 6 p 21 . 31 ( BAK 1 ) influences the risk of chronic lymphocytic leukemia * (2012) (9)
PHYTOHÆMAGGLUTININ IN APLASTIC ANÆMIA (1966) (9)
Ataxia telangiectasia gene mutations and chronic lymphocytic leukaemia (1999) (9)
Treatment of red cell aplasia in CLL with fludarabine (1999) (9)
Hypercalcaemia in T cell acute lymphoblastic leukaemia: report of two cases. (1986) (9)
Intracytoplasmic inclusions in B prolymphocytic leukaemia: ultrastructural, cytochemical, and immunological studies. (1985) (9)
Cytoplasmic inclusions in a case of prolymphocytic leukemia. (1981) (9)
Interleukin-6 and other gp130-dependent cytokines selectively inhibit proliferation of macrophage-lineage hemopoietic progenitor cells. (2000) (9)
[Malignant diseases of the mononuclear phagocytic system]. (1982) (9)
Lack of a relationship between the common 18q24 variant rs12953717 and risk of chronic lymphocytic leukemia (2008) (9)
An eight-way variant t(15;17) in acute promyelocytic leukemia elucidated using fluorescence in situ hybridization. (1995) (9)
Disease Burden of Chronic Lymphocytic Leukemia within the European Union. (2007) (9)
Histomorphological study of cellular interactions between stromal and haemopoietic stem cells in normal and leukaemic bone marrow (1984) (9)
Morphological and immunophenotypical characterization of Japanese B-cell lymphocytic leukemia. (1994) (8)
Preleukemia (1981) (8)
Prolonged treatment response in aggressive natural killer cell leukemia (2005) (8)
UNUSUAL TRANSLOCATIONS IN Ph1 -POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA (1979) (8)
Evaluation of serum markers in the LRF CLL4 trial: β2-microglobulin but not serum free light chains, is an independent marker of overall survival (2016) (8)
Pneumatosis coli in adult acute myeloid leukaemia. (1979) (8)
Lymphocyte Transformation in Immunoproliferative Disorders (1972) (8)
The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry (2012) (8)
The chronic B-cell leukaemias. (1993) (8)
Interleukin-4 enhances the survival of severe combined immunodeficient mice engrafted with human B-cell precursor leukemia. (1996) (8)
Chronic T-cell leukaemias. III. T-colonies, PHA response and correlation with membrane phenotype. (1982) (8)
Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. (1980) (7)
The classification of acute leukaemia (AL) and its clinical significance. (1983) (7)
Ultrastructural, cytochemical and surface marker analysis of cells during blast crisis of chronic granulocytic leukaemia. (1978) (7)
Histological study of the bone marrow in chronic granulocytic leukaemia in blast transformation. I. Serial observations before and after autografting (1981) (7)
Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma (2010) (7)
Current treatment of hairy cell leukaemia (1988) (7)
Predictive Biomarkers and Personalized Medicine Functional Analysis of the ATM-p 53-p 21 Pathway in the LRF CLL 4 Trial : Blockade at the Level of p 21 Is Associated with Short Response Duration (2012) (7)
Current approach to the biology and treatment of chronic lymphoid malignancies other than CLL. (1996) (7)
Pseudoautosomal linkage in chronic lymphocytic leukaemia (2000) (7)
Lack of a relationship between the common 8q24 variant rs6983267 and risk of chronic lymphocytic leukemia (2008) (7)
Teaching cases from the Royal Marsden and St. Mary's Hospitals case 10 microcytic anaemia and thrombocytosis. (1996) (7)
Morphology, atypical chronic lymphocytic leukaemia and prognostic features affecting choice of therapy. (1999) (7)
Functional and phenotypic analysis of a T cell prolymphocytic leukemia. (1985) (7)
Massive retroperitoneal lymphadenopathy as a terminal event in hairy cell leukaemia. (1983) (7)
First report of fludarabine in gamma‐heavy chain disease (1994) (7)
Characterization of a t(I0; II) (pI3‐I4; qI4‐2I) in the monoblastic cell line U937 (1995) (7)
Mutational Status of the TP53 Gene as a Predictor of Response and Survival in CLL Patients with and without 17p Deletion (2008) (6)
The P 2 X 7 Receptor Gene A 1513 C Polymorphism Does Not Contribute to Risk of Familial or Sporadic Chronic Lymphocytic Leukemia (2004) (6)
Proceedings of the international round table conference: FAB classification of acute leukemias correlating with response to chemotherapy. (1984) (6)
Gender as a Prognostic Factor in CLL. Biological Pointers to the Improved Outcome of Women. (2004) (6)
Comparison of Oral and Intravenous Fludarabine in the LRF CLL4 Trial. (2005) (6)
Tseudo‐lymphoid‘ leukaemia with unusual features: Ultrastructural, immunological, cytogenetic and molecular studies (1987) (6)
An unusual variant of T-CLL: evidence for the existence of a hitherto unrecognized T cell subset. (1986) (6)
Clinical, immunological, ultrastructural, and cytogenetic studies in black patients with adult T-cell leukemia/lymphoma. (1984) (6)
Monocytic differentiation induced by 1,25 dihydroxyvitamin D3 in myeloid cells: an ultrastructural immunocytochemical study. (1985) (6)
Buffy coat autografts for patients with chronic granulocytic leukaemia in transformation (1981) (6)
Cytochemical demonstration of lysozyme and nitroblue tetrazolium reduction in leukaemia monocytes. (1972) (6)
Adult acute lymphoblastic leukaemia presenting with bone marrow aplasia. (1986) (6)
The ultrastructural morphology of T lymphocytes in B‐chronic lymphocytic leukaemia: a study with monoclonal antibodies and the immunogold technique (1983) (6)
Hairy cell leukemia: 1986. (1986) (6)
CHEK2*1100delC and risk of chronic lymphocytic leukemia (2006) (6)
Classification of mature T-cell leukemias (2003) (6)
Quantitative flow cytometry can predict childhood acute lymphoblastic leukaemia presenting with aplasia. (1997) (6)
A novel human macrophage-activating factor: Distinction from interferon-γ (IFN-γ) and granulocyte-macrophage colony-stimulating factor (GMCSF) (1988) (6)
Treatment of chronic granulocytic leukaemia with repeated single doses of busulphan. (1979) (6)
Is T-cell CLL a disease entity? (1996) (6)
Aggressive NK cell lymphoma preceded by a ten year history of neutropenia associated with large granular lymphocyte lymphocytosis. (1998) (6)
Teaching cases from the Royal Marsden Hospital. Case 9: an elderly patient with unusual circulating cells. (1995) (6)
Alemtuzumab for Chronic Lymphocytic Leukemia with and without p53 Deletions. (2004) (6)
The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial (2021) (6)
The effect of tetradecanoyl-12, 13-phorbol acetate on 'hairy' cells. (2009) (6)
Atypical promyelocytic leukemia (M3) with immature primary granules and t(15;17). (1985) (5)
Ultrastructure and cell marker studies in lymphoproliferative disorders. (1979) (5)
Studies on cellular interactions between stromal and haemopoietic stem cells in normal and leukaemic bone marrows. (1984) (5)
Bone Marrow Transplantation for Patients in the Chronic Phase of Chronic Granulocytic Leukaemia: Apparent Low Incidence of Relapse within the First Two Years Post-BMT (1985) (5)
Increase in T? Lymphocytes in B-Cell Chronic Lymphocytic Leukaemia (2009) (5)
Cytogenetic Studies on Prolymphocytic Leukemia (2005) (5)
The Leukemia Cell (1980) (5)
Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40. (1995) (5)
Clinical and laboratory features of adult T-cell leukaemia lymphoma in Barbados. (1996) (5)
An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapy (2015) (5)
Differential expression of c-myc protein in B and T lymphocytes. (1994) (5)
Breakpoints in the ataxia telangiectasia gene arise at the RGYW somatic hypermutation motif (2002) (5)
Chronic lymphocytic leukaemia presenting with bilateral breast involvement. (1989) (5)
Group 1996 guidelines Working - Lymphocytic Leukemia updating the National Cancer Institute leukemia: a report from the International Workshop on Chronic Guidelines for the diagnosis and treatment of chronic lymphocytic (2008) (5)
Clinical Outcome of Stem Cell Transplantation(SCT) in Patients with T Cell Prolymphocytic Leukaemia(T-PLL) Previously Treated with Alemtuzumab: A Multicentre Experience. (2005) (5)
Bilineal acute leukemia of B and T lineage with a novel translocation t(9;17)(p11;q11). (1997) (5)
Phenoxyethanol is effective topical therapy of gram-negative cellulitis in neutropenic patients. (1993) (5)
Prolymphocytic leukaemia: surface morphology in 21 cases as seen by scanning electron microscopy and comparison with B‐type CLL and CLL in ‘prolymphocytoid’ transformation (1984) (5)
Inherited Predisposition to Chronic Lymphocytic Leukemia (2004) (5)
Two unbalanced translocations, t(12;22)(p13;q11) and t(12;?)(p13;?), in an aggressive chronic B-cell leukemia: TEL gene analysis using FISH. (1997) (5)
Method for the simultaneous labelling of terminal deoxynucleotidyl transferase (TdT) and membrane antigens. (1984) (5)
Quality of Life in the LRF CLL4 Trial. (2005) (5)
Germline mutations in Dok1 do not predispose to chronic lymphocytic leukemia. (2005) (5)
Coexpression of T- and B-markers in a lymphoproliferative disorder. (2009) (5)
Del(9q) acute myeloid leukaemia: clinical and cytological characteristics and prognostic implications (2005) (5)
SPLENECTOMY FOR COMPLICATIONS OF CHRONIC GRANULOCYTIC LEUKÆMIA (1975) (5)
Deletions of D13S25, D13S319 and RB‐1 mapping to 13q14.3 in T‐cell prolymphocytic leukaemia (2001) (5)
Dipeptidylaminopeptidase IV (DAP IV) in B- and T-cell leukaemias. (1985) (4)
REARRANGEMENT OF THE T-CELL RECEPTOR DELTA (TCR-DELTA GENES IN HUMAN T-CELL LEUKEMIAS (1988) (4)
Characterization of a t(10;11)(p13-14;q14-21) in the monoblastic cell line U937. (1995) (4)
Teaching Cases from the Royal Marsden (1993) (4)
Facultative phagocytosis by leukemic B-lymphocytes: further proof of the B-cell nature of hairy cells. (1978) (4)
Flow-cytometry detection of minimal DNA aneuploidy in mature lymphoid leukemias - comparison with metaphase and interphase cytogenetics. (1994) (4)
Inhibitory effect of cyclosporin A on peripheral blood and bone marrow T lymphocyte colony formation. (1981) (4)
Morphological recognition of lymphocytes and macrophages. (1976) (4)
Response to phytohaemagglutinin and pokeweed mitogen in chronic lymphocytic leukemia. (1972) (4)
T gamma cell deficiency in idiopathic thrombocytopenic purpura (ITP). (1981) (4)
The first report of familial adult T‐cell leukaemia lymphoma in the United Kingdom (1995) (4)
The WHO classification of mature T-cell leukemias. Authors' reply (2004) (4)
Teaching cases from the Royal Marsden and St Mary's Hospitals. Case 13: an orbital mass in a young girl. (1998) (4)
THE THIRD INTERNATIONAL WORKSHOP ON HAIRY CELL LEUKEMIA, LAGUNA NIGUEL, CALIFORNIA, 19–20 OCTOBER 1989 (1990) (4)
Symposium: Classification of Leukemia 1. The Classification of Acute Leukemiaxs (1982) (4)
THE NATURE OF T‐CHRONIC LYMPHOCYTIC LEUKAEMIA (1986) (4)
Study of the peripheral blood leucocyte population by Fourier analysis of the cell volume histogram. (1978) (4)
A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia (2022) (4)
The Lack of Survival Differences in Randomised Trials in CLL May Be Related to the Effect of Second Line Therapies. A Report from the LRF CLL4 Trial. (2006) (4)
Incomplete Reiter's syndrome following chemotherapy of acute myeloid leukaemia. (1986) (4)
Combinations of ZAP-70, CD38 and IgVH Mutational Status as Predictors of Time to First Treatment in CLL. (2005) (4)
Unusual deletions within the immunoglobulin heavy-chain locus in acute leukemias (1993) (3)
SIGNIFICANCE OF SPLENOMEGALY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKÆMIA IN REMISSION (1980) (3)
The genomic breakpoint in a patient with Philadelphia-positive acute leukemia is 5' of the breakpoint cluster region. (1988) (3)
Loci other than 21q22.12 (RUNX1) and 16q21–23.2 cause familial AML (2005) (3)
T-lymphocyte colonies in human cord blood. (1980) (3)
Teaching cases from the Royal Marsden Hospital. Case 7: an east African with fever. (1993) (3)
T-lymphocytes in B-cell chronic lymphocytic leukaemia. (1981) (3)
Fluorescent BAT-25 and BAT-26 analysis of T cell prolymphocytic leukaemia (1999) (3)
Normal helper T-cell function in hairy-cell leukaemia. (2009) (3)
T or B lymphocytes in chronic lymphocytic leukemaemia. (1971) (3)
p53 protein overexpression in bone marrow biopsies from chronic lymphocytic leukaemia is associated with TP53 deletion and resistance to fludarabine (2010) (3)
Immunoblastic transformation of a Sezary syndrome in a black Caribbean patient without evidence of HTLV-I. (1995) (3)
Follicular Lymphoma. A Series of 11 Patients with Minimal or no Treatment and Long Survival (2000) (3)
Melphalan Versus Cyclophosphamide with Total-Body Irradiation as Conditioning for Allogeneic Bone-Marrow Transplantation in 1St Remission Acute Myeloid-Leukemia (1994) (3)
Drug Sensitivity by TRAC (DiSC) Assay as a Prognostic Factor for Patient Response in Untreated CLL: Results from the UK LRF CLL4 Trial. (2006) (3)
Genetic variation in CXCR 4 and risk of chronic lymphocytic leukemia (2009) (3)
Increase in 2′,5′‐oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemia (1992) (3)
Teaching cases from the Royal Marsden and St Mary's Hospitals. Case 14: persistent lymphocytosis in a middle aged smoker. (1998) (3)
B- Prolymphocytic Leukemia Shows Heterogeneous IgVH Mutational Status and Expression of ZAP-70 and CD38. (2004) (3)
Spectrum of Reactivity with Three Monoclonal Antibodies-MHM6(CD23), L30(CD24) and UCHB1-in B-Cell Leukaemias. (1990) (3)
Lysosomal granules in leukemic monocytes and their relation to maturation stages. (1981) (3)
Ultrastructural cytochemistry of chronic T-cell leukaemias. A study with four acid hydrolases (1983) (3)
Partial trisomy of chromosome 4 resulting from a novel t[4;7) translocation in a case of AML M2 with eosinophilia. (1996) (2)
Characterisation of TP 53 abnormalities in chronic lymphocytic leukaemia (2004) (2)
POSSIBLE ASSOCIATION OF DISSEMINATED INTRAVASCULAR COAGULATION (DIC) WITH THE CHROMOSOMAL REGION 17q 12–21 AND THE GENE FOR GLYCOPROTEIN IIb‐IIIa COMPLEX (1988) (2)
Quantitative expression of CD 23 and its ligand CD 21 in chronic lymphocytic leukemia (2000) (2)
Prognosis in acute myeloid leukaemia. (1981) (2)
Monocytes, Monocytosis and Monocytic Leukemia (1974) (2)
High Incidence of Myelodysplasia and Secondary Leukemia in the UK MRC Pilot Study of Autografting in Chronic Lymphocytic Leukemia. (2005) (2)
Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies (2021) (2)
High Grade Transformation in Splenic Marginal Zone Lymphoma: A Description of a Series of 8 Cases. (2006) (2)
The contribution of gene mutations to long-term clinical outcomes: data from the randomised UK LRF CLL4 trial (2017) (2)
Appendix 2: WHO Classification of Tumours of Haemopoietic and Lymphoid Tissues (2005) (2)
HISTIOCYTIC MEDULLARY RETICULOSIS AND ACUTE LYMPHOBLASTIC LEUKAEMIA (1982) (2)
Significance of Cell Differentiation in Acute Myeloid Leukaemia (1975) (2)
4.18 The Clinical Significant of NOTCH1 and MYD88 Mutations in Patients Enrolled onto the UK CLL4 Treatment Trial and in an Early Stage A CLL Cohort (2011) (2)
Teaching cases from the Royal Marsden and St Mary's Hospitals. Case 15: uterine mass in an asymptomatic female. (1998) (2)
Case 17: Essential thrombocythaemia with inversion 3 terminating in acute leukaemia. (1998) (2)
Cytochemical profile ofB and T leukaemic lymphocytes with special reference to acute lymphoblastic leukaemia (2)
The Association between Deaths Due to Infection and Mutations of the BRAF, FBXW7, NRAS and XPO1 genes: A Report from the LRF CLL4 Trial (2020) (2)
Rituximab, Either As Single Agent or in Combination, Is Superior to Other Treatments in Terms of Response Rate and Progression-Free Survival (PFS) in Patients with Splenic Marginal Zone Lymphoma (SMZL) (2011) (2)
Increase in 2',5'-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemia. (1991) (2)
The Treatment of CLL: Summing up. (1991) (2)
Monoclonal Antibodies in Haematopathology (1987) (2)
G-CSF mobilization of haemopoietic cell populations in SCID mice engrafted with human leukaemia (1997) (2)
1,25(OH)2D3 causes monocytic differentiation of normal human bone marrow in vitro (1983) (2)
Fourth International Workshop on Chromosomes in Leukemia 1982: Correlation between morphology and karyotype. (1984) (2)
Binucleated blast-cells in lymphocyte cultures from myelomatosis. (1972) (2)
Morphological and cytochemical features of adult T-cell lymphoma-leukaemia. (1983) (2)
Minimal residual disease in children with acute lymphoblastic leukaemia (1998) (2)
C-TYPE PARTICLES IN CELLS FROM T-CELL LYMPHOMA/LEUKAEMIA AFTER 5-7 DAYS' CULTURE (1983) (2)
The changing face of chronic lymphocytic leukemia (2007) (2)
Lymphocyte survival and macrophage growth in long term in vitro leucocyte cultures (2005) (2)
1,25-DIHYDROXYVITAMIN D3 AND MYELOFIBROSIS (1984) (2)
Phytohaemagglutinin in aplastic anaemia. (1967) (2)
A novel human macrophage-activating factor: distinction from interferon-gamma (IFN-gamma) and granulocyte-macrophage colony-stimulating factor (GMCSF). (1988) (2)
Studies with the monoclonal-antibodies (MCAB) BI-3C5 and M906 in normal and leukemic-cells (1984) (1)
B Prolymphocytic Leukemia Cell Lines: Phenotype and Response to B Cell Differentiation Factor (1988) (1)
Expression ofTIA-1andTIA-2inT cell malignancies andT cell lymphocytosis (1996) (1)
Monoclonal Antibody BI-3C5 Reacts Specifically with M1/M2-Acute Myeloid Leukaemias and Most Non-B Non-T Acute Lymphocytic Leukaemias, and Recognises A Small Population of Immature Cells in Normal Bone Marrow (1985) (1)
The Clinical Presentation of CLL (2019) (1)
Association between SNP-genotype and chronic lymphocytic leukemia outcome in a randomized chemotherapy trial (2011) (1)
Ultrastructural analysis of normal and leukaemic cells by the immunogold method and monoclonal antibodies. (1985) (1)
Inhibition of T-lymphocyte colony formation by inhibitors of mitochondrial protein synthesis. (1980) (1)
IMMUNOGLOBULIN GENE REARRANGEMENT IN LYMPHOCYTIC-LEUKEMIA (1984) (1)
COLLABORATIVE META-ANALYSIS OF RANDOMISED TRIALS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) (1998) (1)
Chronic Lymphocytic Leukaemia (2001) (1)
Defining response criteria in CLL patients treated in clinical research trials Response (2010) (1)
Etiology and Epidemiology of CLL (2013) (1)
Royal Marsden teaching cases. An elderly man with weight loss and anaemia. (1996) (1)
Long-Term Follow-up of 228 Hairy Cell Leukemia Patients Treated with Pentostatin or Cladribine with 15.4 Years Median Time from Diagnosis. (2008) (1)
Microsatellite instability indicative of defects in the major mismatch repair genes is rare in patients with B-cell chronic lymphocytic leukemia: Evaluation with disease stage and family history (2007) (1)
Molecular characterisation of a new recurrent abnormality of chromosome 12q24 in lymphoid malignancies. (1998) (1)
T-CELL LEUKAEMIAS WITH "HELPER" PHENOTYPE IN ADULTS (1985) (1)
Chapter 14 – Immunophenotyping (2006) (1)
A death from Langerhans cell histiocytosis and tuberculosis in 18th Century Hungary - what palaeopathology can tell us today (2006) (1)
Comparison of IgH Gene Rearrangement Configuration between Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia Variant (HCL-v). (2005) (1)
Increased proportion of Fc gamma and Fc mu positive T-lymphocytes following treatment with neuraminidase. (1980) (1)
Timing of transplant for CML patients. (1984) (1)
4th International workshop on CLL (1989) (1)
Familial multiple myeloma. (2005) (1)
ZAP-70 Expression in Chronic Lymphocytic Leukemia: Correlation with Clinical and Biological Features. (2004) (1)
Monoclonal antibodies detecting plasminogen activators on the membrane of leukemic lymphoid cells of T-cell origin. (1987) (1)
Osteolytic lesion as the presenting feature of chronic granulocytic leukaemia. (1985) (1)
Alkaline phosphatase in human lymphocyte subpopulations (1979) (1)
[CYTOCHEMICAL DETERMINATION OF ALKALINE PHOSPHATASE, ACID PHOSPHATASE, ARYLSULPHATASE AND PEROXIDASES]. (1965) (1)
High Dose Methylprednisolone and Rituximab Is an Effective Therapy in Advanced Refractory Chronic Lymphocytic Leukaemia Resistant to Fludarabine Therapy. (2007) (1)
Telomere Length Is An Independent Predictor of Outcome After Therapy in CLL: Results From the UKCLL4 Trial, (2011) (1)
Correlation of lymphocyte β-glucuronidase andN-acetyl-β-glucosaminidase with E-rosette formation (1983) (1)
BRCA2 in chronic lymphocytic leukemia Frequent somatic deletion of the 13q12.3 locus encompassing (2011) (1)
[THE ALKALINE PHOSPHATASE REACTION IN THE NEUTROPHIL LEUKOCYTES OF THE HUMAN BLOOD]. (1963) (1)
rs2072135, a low‐penetrance variant for chronic lymphocytic leukaemia? (2013) (1)
MANAGEMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA (1998) (1)
Treatment of chronic granulocytic leukemia in the chronic phase by allogeneic bone marrow transplantation (1983) (1)
Interferon‐γ+ and interleukin‐2+ T cells in peripheral blood from multiple myeloma patients in relation to disease status and maintenance therapy with interferon‐α2b (intron A) (1997) (1)
The Combination of Fludarabine and Cyclophosphamide Has a Beneficial Effect on the Incidence of Hemolytic Anemia in Chronic Lymphocytic Leukemia. Results from the UK LRF CLL4 Trial. (2007) (1)
Changes in surface antigens of HL-60 cells during differentiation in vitro (1984) (1)
9th Symposium Molecular Biology of Hematopoiesis (Part 4 of 12) (1995) (1)
Differential expression ofT cell antigens in normalperipheral bloodlymphocytes: a quantitative analysis byflowcytometry (1996) (1)
Remission of the nephrotic syndrome associated with chronic lymphocytic leukaemia. (1986) (1)
Timing of transplant for CML patients (letter) (1984) (1)
lymphocytic leukemia Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic (2013) (1)
Ultrastructural study of normal and leukaemic leucocyte processes. (1978) (1)
Appendix I: Normal Values (2010) (1)
[Phenotypical diagnosis of Japanese chronic lymphocytic leukemia--an international cooperative study based on the French-American-British classification of mature B-cell leukemias]. (1995) (1)
Response: Letters regarding Blood. 2008;111:5446-5456 by Hanson et al and Mulligan et al (2009) (1)
Hairy cell leukemia (HCL) and hairy cell leukemia variant (HCL-V) (2011) (1)
Neoplastic kappa and lambda cells in a B-PLL with chromosome translocations of both light chain gene regions. (1984) (1)
[Membrane receptors in acute monocytic leukaemia (author's transl)]. (1978) (1)
lymphocytic leukemia ) influences the risk of chronic BAK1 (2012) (1)
Splenic Lymphoma With Villous Lymphocytes: Analysis (2002) (1)
The human leucocyte P30 antigen: properties and assessment of value as a clonal marker. (2008) (1)
Ultrastructural Analysis of B- and T-Lymphocyte Subsets with the Immunogold Technique (1984) (1)
B-Prolymphocytic Leukemia (B-PLL) (2001) (1)
Hypercalcaemia inTcell acutelymphoblastic leukaemia: reportoftwocases (1986) (0)
Megakaryoblastic transformation ofchronic granulocytic leukaemia Anelectron microscopy andcytochemical study (2017) (0)
Contents, Vol. 19, 1977 (1977) (0)
Proceedings: Cytochemistry of leucocytes. (1975) (0)
susceptibility in familial chronic lymphocytic leukemia related genetic - Linkage analysis for major histocompatibility complex (2013) (0)
A tribute to Professor Terence “Terry” John Hamblin (2012) (0)
Hairy cell leukemia (HCL). (2001) (0)
Interferon as an alternative to purine analogues in the treatment of hairy cell leukaemia – response to Benz et al (2010) (0)
A comparison of oral and intravenous fludarabine in the LRF CLL4 trial (on behalf of the UKNCRI CLL trials group) (2006) (0)
chronic lymphocytic leukemia Perspectives on the use of new diagnostic tools in the treatment of (2013) (0)
It is recommended that you download this PDF to your computer for furture reference. It spells out how CLL is treated clinically. (2008) (0)
Morphology in hematology. (1994) (0)
Intra-Lineage Phenotypic Switch in T-Cell Prolymphocytic Leukemia. (2004) (0)
Molecular cloning of translocation t defines a novel gene at chromosome 1q21 (1997) (0)
Cellular/cytogenetic events in CLL. (1996) (0)
Familial chronic lymphocytic leukemia (2008) (0)
Baseline Characteristics Associated with Quality of Life in CLL Patients Requiring Therapy. (2007) (0)
9th Symposium Molecular Biology of Hematopoiesis (Part 2 of 12) (1995) (0)
9th Symposium Molecular Biology of Hematopoiesis (Part 11 of 12) (1995) (0)
The Outcome of CLL Patients with 97% Identity to Germline Is Inferior to Other ‘Mutated’ Cases Defined by a 98% Cut off (2011) (0)
WellferonR Efficacy in the Treatment of Hairy Cell Leukaemia (HCL) (1987) (0)
PROPHYLACTIC CO-TRIMOXAZOLE IN LEUKÆMIA (1978) (0)
Adult acutelymphoblastic leukaemia: A study ofprognostic features andresponsetotreatment overa tenyearperiod (1986) (0)
Current concerns inhaematology 2:Classification ofacute leukaemia (1990) (0)
Contents Vol. 98, 1997 (1997) (0)
Reversal of myelofibrosis in acute megakaryoblastic leukaemia following allogeneic marrow transplantation (1983) (0)
B-Cell Prolymphocytic Leukemia (B-PLL) and Chronic Lymphocytic Leukemia (CLL) Express Distinct Genomic Profiles. (2005) (0)
Deregulated Expression of HDAC9 in B-Cells Leads to Lymphoproliferative Disorders As Well As Germinal Center and Post-Germinal Center Derived Lymphomas (2012) (0)
Associations between Chromosomal Aberrations and Functional Impairment of the P53 Pathway in Chronic Lymphocytic Leukaemia. (2004) (0)
9th Symposium Molecular Biology of Hematopoiesis (Part 12 of 12) (1995) (0)
Teaching cases from the Royal Marsden Hospital. Case 16: T-cell non Hodgkin's lymphoma associated with hypercalcaemia in a black Caribbean. (1998) (0)
[Phagocytosis studied in vivo with the skin window method. Observations on normal human serum and in hemopathies]. (1967) (0)
Diagnostic features of leukaemic reticuloendotheliosis. (1973) (0)
Teaching Cases from the Royal Marsden Hospital Case 3: a lymphoproliferative disorder of 17 years duration (1992) (0)
Massive retroperitoneal lymphadenopathy in hairy cell leukaemia (1983) (0)
Book reviews (2004) (0)
B-lymphocyte expansion Inherited predisposition to CLL is detectable as sub-clinical monoclonal (2013) (0)
12. PROLYMPHOCYTIC LEUKEMIA (1984) (0)
antibody FMC7 Heterogeneity of B-cell leukemias demonstrated by the monoclonal (2011) (0)
Abstract (1984) (0)
Teaching cases from the Royal Marsden Hospital. Case 6: a man with a large cervical mass. (1992) (0)
Circulating Ki67positive lymphocytes in multiple myelomaandbenign monoclonal gammopathy (1995) (0)
Successful treatment of extranodal Hodgkin's lymphoma in a patient with longstanding hairy cell leukemia (2005) (0)
Lymphocyte cultures in multiple myeloma and other paraproteinaemias. (1969) (0)
CLL variants and T-cell-related issues. (2000) (0)
[Synthesis of surface immunoglobulins in prolymphocytic leukaemia (author's transl)]. (1979) (0)
through analysis of IgVH gene usage and mutation status in familial Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) (2013) (0)
Subject Index Vol. 98, 1997 (1997) (0)
Deoxycoformycin inthetreatment ofmatureB-cell malignancies (1990) (0)
B-cell prolymphocytic leukemia and hairy cell leukemia: new advances in biology and treatment (2012) (0)
DISAPPEARANCE OF HÆMATOLOGIST IN ARGENTINA (1978) (0)
Demonstration ofcytoplasmic andnuclear antigens inacute leukaemia using flowcytometry (1994) (0)
Morphologic and Immunophenotypic Variants of Chronic Lymphoproliferative Disorders (1993) (0)
ZAP70 Methylation Is An Independent Prognostic Biomarker For Front Line Therapy Of Chronic Lymphocytic Leukemia : Results From The UK LRF CLL4 Trial (2013) (0)
Diseases of the lymphatic system, diagnosis and therapy: Edited by D. W. Molander, 340 pages, 111 figs. Price U.S. $71.70, Springer, New York, 1984 (1985) (0)
defines an activation antigen on normal CD8+ T cells (see comments) B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also (2011) (0)
Theleukaemic phaseofnon-Hodgkin's lymphoma (1995) (0)
Subject Index Vol. 19, 1977 (1977) (0)
Leucemia linfática crónica familiar: La predisposición genética de la LLC y la linfocitosis monoclonal de células B Overview of familial chronic lymphocytic leukaemia: The genetic susceptibility to chronic lymphocytic leukaemia and monoclonal B-cell lymphocytosis (2018) (0)
Diagnosis of lymphoid malignancies (1992) (0)
Teaching Cases from the Royal Marsden Hospital Case 1: a young man with petechiae and splenomegaly. (1991) (0)
Teaching cases from the Royal Marsden Hospital. Case 5: a child with fever, hepatosplenomegaly and cytopenia. (1992) (0)
Antigenic phenotype of leukaemic progenitor cells (AML-CFU-L) in three cases of megakaryocytic leukaemia (1986) (0)
Telomere Length and CD49d Cooperate with IGHV Gene Status As Predictors of Long-Term Progression-Free Survival in CLL Patients Treated with FCR-Based Regimens (2020) (0)
9th Symposium Molecular Biology of Hematopoiesis (Part 3 of 12) (1995) (0)
Tγ Cell Deficiency in Idiopathic Thrombocytopenic Purpura (ITP) (2009) (0)
International grand round. Myeloma Grand Round (2001) (0)
fludarabine plus cyclophosphamide in chronic lymphocytic leukemia is an independent determinant of inferior response to CYP2B6*6 (2014) (0)
[Localization of acid phosphatase in the cells of the hemolymphopoietic tissue and inflammatory exudates at pH 5 and 6.3]. (1965) (0)
PF355 INTEGRATION OF GENOMIC AND EPIGENOMIC DATA REFINES THE REGULATORY MECHANISMS AND BIOLOGICAL SIGNIFICANCE OF CHRONIC LYMPHOCYTIC LEUKEMIA RISK LOCI (2019) (0)
[The clinical and laboratory characteristics of mature (postthymic) T-cell malignant neoplasms]. (1993) (0)
High Resolution Genomic Profiling Using Single Nucleotide Polymorphism Microarrays Reveals Novel Genomic Lesions in Hairy Cell Leukaemia and Hairy-Cell Leukaemia Variant (2008) (0)
Bone-Marrow Transplantation for Acute Promyelocytic Leukemia (1993) (0)
Allelic loss of 13q14 at the D13S25 locus but not RB1 or trisomy 12 is an independent prognostic factor on survival in chronic lymphocytic leukemia (1997) (0)
Proceedings: Methods for the study and cell differentiation in acute leukaemia. (1975) (0)
Gene Expression Profiling Classifies Splenic Marginal Zone Lymphoma and Hairy Cell Leukemia-Variant as Related Diseases That Are Distinct From Typical Hairy Cell Leukemia.: 51st Annual Meeting of the American-Society-of-Hematology (2009) (0)
leukemia immunodeficient mice engrafted with human B-cell precursor Interleukin-4 enhances the survival of severe combined (2011) (0)
identifies susceptibility loci for chronic lymphocytic leukemia A high-density SNP genome-wide linkage search of 206 families (2013) (0)
Outcomes in Patients with Splenic Marginal Zone Lymphoma or Marginal Zone Leukemia/Lymphoma Treated with Immunotherapy, Chemoimmunotherapy, or Chemotherapy. (2005) (0)
Correlation of lymphocyte beta-glucuronidase and N-acetyl-beta-glucosaminidase with E-rosette formation. (1983) (0)
The clinical significance of the FAB classification of acute and chronic leukaemias (1994) (0)
9th Symposium Molecular Biology of Hematopoiesis (Part 9 of 12) (1995) (0)
Gene Expression Reveals Two Distinct Biological Groups within T-Cell Prolymphocytic Leukaemia. (2005) (0)
Immunophenotyping (Chapter 14) (2001) (0)
LYMPHOID NEOPLASIA Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia (2016) (0)
Abnormalities in B-Cell Prolymphocytic (1997) (0)
9th Symposium Molecular Biology of Hematopoiesis (Part 1 of 12) (1995) (0)
Contents, Vol. 93, 1995 (1995) (0)
lymphoma/leukemia patients from the Caribbean Functional properties of neoplastic T cells in adult T cell (2011) (0)
Autografting for Acute Myeloid-Leukemia in 1St Remission - Evaluation of a Conditioning Regimen Containing Melphalan and Identification of Modifiable Treatment-Related Prognostic Factors (1994) (0)
Studies on the P53 gene and protein expression in sezary syndrome (SS) and T-prolymphocytic leukaemia (T-PLL). (1998) (0)
[Membrane markers in chronic lymphoproliferative diseases]. (1983) (0)
Leukemia and myelomatosis. (1987) (0)
Teaching cases from the Royal Marsden Hospital. Case 8: a Japanese patient with leukaemia and headache. (1993) (0)
Immunological studies inacaseofT-cell leukaemia (1974) (0)
the MRC Pilot Study safe and achieves a high percentage of molecular responses. Results of Autografting for younger patients with chronic lymphocytic leukaemia is (2013) (0)
Age group General population Normal relatives from CLL families Relative risk (95% CI) P-value (Fisher's exact test) (2006) (0)
Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion (2000) (0)
acute leukemia Analysis of clonal rearrangements of the Ig heavy chain locus in (2011) (0)
Recent Results in Cancer Research, Vol 93, Leukemia Recent Developments in Diagnosis and Therapy; Edited by E. Thiel & S. Thierfelde, Springer‐Verlag, Berlin, 1984, 350 pages, US$46.60 (1985) (0)
Contemporary issues in Clinical Oncology: Leukemias and Lymphomas Edited by P.H. Wiernik. Churchill Livingstone, New York, 1985, 287 pages, £36 (1985) (0)
9th Symposium Molecular Biology of Hematopoiesis (Part 6 of 12) (1995) (0)
Subject Index Vol. 93,1995 (1995) (0)
B- Cell Chronic Lymphocytic Leukaemia Complicated by Aggressive T-Cell Lymphoma: Clinical and Molecular Analysis of a Rare Variant of Richter’s Syndrome. (2005) (0)
CHARACTERIZATION OF BLAST CELLS BY ULTRASTRUCTURAL CYTO-CHEMISTRY AND MONOCLONAL-ANTIBODIES (1983) (0)
Obituary. David Abraham Goitein Galton. (2007) (0)
Brief report Common variation at 6p21.31 ( BAK1 ) inﬂuences the risk of chronic lymphocytic leukemia (2012) (0)
Clinico-biological significance of DNA methylation in chronic lymphocytic leukaemia patients: results from three UK clinical trials (2020) (0)
Teaching Cases from the Royal Marsden Hospital Case 4: fever, hepatic dysfunction and cytopenia (1992) (0)
Etiology and Epidemiology of Chronic Lymphocytic Leukemia (2018) (0)
Bacterial Artificial Chromosome (BAC) Array CGH Study of B-CLL Patients with 17p13 Deletion. (2005) (0)
NON-CODING NOTCH1 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKAEMIA; THEIR CLINICAL IMPACT IN THE CLL4 CLINICAL TRIAL (2016) (0)
Response to deoxycoformycin in T cell leukaemias (1988) (0)
Biphenotypic leukaemia: a caseofmixed Tlymphoblastic andmyeloblastic leukaemia (1985) (0)
Long-term in vitro lymphocyte culture. (1970) (0)
9th Symposium Molecular Biology of Hematopoiesis (Part 5 of 12) (1995) (0)
Classification of T-Cell disorders (2011) (0)
Teaching Cases from The Royal Marsden and St Mary's Hospitals. Case 22: An Unusual Cause of Lymphocytosis (2002) (0)
TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA WITH THE HUMANISED CD52 MONOCLONAL ANTIBODY CAMPATH-1H (1995) (0)
9th Symposium Molecular Biology of Hematopoiesis (Part 8 of 12) (2004) (0)
Monoclonal antibody bi 3c 5 of use in the classification of acute leukemias (1985) (0)
Leukaemias and mature T cells (Chapter 43) (2001) (0)
Methodforthe'simultaneous labelling ofterminal deoxynucleotidyl transferase (TdT)andmembrane antigens (2012) (0)
Treatment options for T-cell large granular lymphocyte leukemia - A case series with review of the literature (2007) (0)
9th Symposium Molecular Biology of Hematopoiesis (Part 7 of 12) (1995) (0)
The identification of specific cell populations in lymphoproliferative diseases (1982) (0)
Allogeneic Bone-Marrow Transplantation for Primary Resistant Acute-Leukemia (1993) (0)
9th Symposium Molecular Biology of Hematopoiesis (Part 10 of 12) (1995) (0)
CHILDHOOD BIPHENOTYPIC LEUKAEMIA : THE ROYAL MARSDEN EXPERIENCE. 160 (1997) (0)
Germline mutations in SPI1 and MADD do not contribute to familial chronic lymphocytic leukaemia (2007) (0)
Morphological of Adult TCe 11 and Cytochemical Features Lymphoma-Leukaemia (0)
T-Cell large granular lymphocytic leukemia, T-cell prolymphocytic leukaemia and aggressive natural-killer cell leukemia/lymphoma. (2004) (0)
Genomewide Linkage Analysis of Chronic Lymphocytic Leukemia by Use of a High-Density Single Nucleotide Polymorphism Assay Containing 11,555 Markers. (2004) (0)
The White Cell (1976) (0)
SURVIVAL AFTER RELAPSE IN ACUTE MYELOID LEUKÆMIA (1978) (0)
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology (2018) (0)
Liposomal vincristine treatment of human leukaemia in severe combined immunodeficient mice (1997) (0)
Teaching Cases from the Royal Marsden Hospital Case 2: a young man with bruising. (1991) (0)
Genome-Wide Profiling of DNA Copy Number Variation in CLL Cases Lacking 17p- (TP53) or 11q- (ATM) Abnormalities Selected from the CLL4 Study (2008) (0)
[Detection of viral antigens in human leukemias]. (1974) (0)
Combined aCGH and Mutational Analysis of CLL Patients with 17p Deletion. (2006) (0)
Abstract 3306: The clinical importance of DNA methylation signatures in chronic lymphocytic leukemia patients treated with chemo-immunotherapy (2018) (0)
Early clinical trials in chronic lymphocytic leukaemia in the UK (2020) (0)
Acknowledgement to referees (2020) (0)
Gene Expression Profiling Classifies Splenic Marginal Zone Lymphoma and Hairy Cell Leukemia-Variant as Related Diseases That Are Distinct From Typical Hairy Cell Leukemia. (2009) (0)
CLADRIBINE AS FRONTLINE TREATMENT OF HAIRY CELL LEUKEMIA: A MULTICENTER EUROPEAN EXPERIENCE OF MORE THAN 30 YEARS ON 384 PATIENTS (2021) (0)
On the causes of hypogammaglobulinaemia in B-CLL. (1982) (0)
A tribute to Professor David A.G. Galton (2007) (0)
identification of genetic variants influencing prognosis Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the (2013) (0)
[CYTOCHEMICAL STUDIES IN A CASE OF DI GUGLIELMO'S SYNDROME]. (1963) (0)
Appendix 1: Normal Values (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Daniel Catovsky?

Daniel Catovsky is affiliated with the following schools:

Daniel Catovsky's Academic­Influence.com Rankings

Why Is Daniel Catovsky Influential?

Daniel Catovsky's Published Works

Published Works

What Schools Are Affiliated With Daniel Catovsky?

Daniel Catovsky's AcademicInfluence.com Rankings